CorMedix (CRMD) Selling, General & Administrative (2010 - 2026)
CorMedix (CRMD) reported Selling, General & Administrative of $15.09 million for Q2 2026, up 58.7% from $9.5 million a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CorMedix's Selling, General & Administrative came in at $73.61 million, up 123.8% year-over-year; for FY2025, it was $68.22 million, up 127.7% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 37.5% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $29.96 million in FY2024 (+69.4%), $17.69 million in FY2023 (-11.6%), $20.01 million in FY2022 (+22.4%) and $16.35 million in FY2021 (+17.8%).
- Five-year quarterly Selling, General & Administrative spans a low of $3.74 million in Q3 2023 and a high of $25.45 million in Q3 2025.
- The high point for year-over-year Selling, General & Administrative in five years was Q3 2025 (growth of 286.7%); the low point was Q2 2023 (a decline of 25.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | CorMedix | 558.43 Mn | -94.09 Mn | 77.13 Mn | 15.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.09 Mn |
| Dec 31, 2025 | 23.57 Mn |
| Sep 30, 2025 | 25.45 Mn |
| Jun 30, 2025 | 9.50 Mn |
| Mar 31, 2025 | 9.69 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 6.58 Mn |
| Jun 30, 2024 | 7.56 Mn |
| Mar 31, 2024 | 8.71 Mn |
| Dec 31, 2023 | 5.22 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.75 Mn |
| Mar 31, 2023 | 7.61 Mn |
| Dec 31, 2022 | 5.58 Mn |
| Sep 30, 2022 | 4.63 Mn |
| Jun 30, 2022 | 5.05 Mn |
| Mar 31, 2022 | 4.75 Mn |
| Dec 31, 2021 | 4.55 Mn |
| Sep 30, 2021 | 3.84 Mn |
| Jun 30, 2021 | 3.36 Mn |
API Access
CorMedix Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();